May 8 |
LEVI
|
GXO Logistics’ Q1 revenue increases 6% to $2.46B |
May 8 |
CSTL
|
Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result |
May 8 |
LEVI
|
Levi’s Voting Initiative Targets Community College Students |
May 7 |
CSTL
|
Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know |
May 7 |
LEVI
|
Levi Strauss & Co's Dividend Analysis |
May 7 |
LEVI
|
GXO to manage Levi Strauss’ distribution centre in Germany |
May 6 |
LEVI
|
Levi’s Scales Use of Transitional Cotton, Plant-Based Indigo |
May 6 |
LEVI
|
Wolverine's (WWW) Q1 Earnings Coming Up: What Lies Ahead? |
May 6 |
CSTL
|
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable |
May 6 |
DBI
|
Designer Brands (NYSE:DBI) Is Reinvesting At Lower Rates Of Return |
May 6 |
LEVI
|
Micron, Qualcomm And 2 Other Stocks Insiders Are Selling |
May 6 |
LEVI
|
Best Income Stocks to Buy for May 6th |
May 5 |
CSTL
|
Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts |
May 5 |
CSTL
|
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript |
May 4 |
CSTL
|
Castle Biosciences, Inc. (CSTL) Q1 2024 Earnings Call Transcript |
May 3 |
CSTL
|
DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck |
May 2 |
CSTL
|
Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ... |
May 2 |
CSTL
|
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates |
May 2 |
CSTL
|
Castle Biosciences beats Q1 estimates, raises FY guidance |
May 2 |
CSTL
|
Castle Biosciences Reports First Quarter 2024 Results |